3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Peripheral Nervous System Diseases
3
Lymphoma
3
Lymphoma, Large B-Cell, Diffuse
2
Breast Neoplasms
2
Wilms Tumor
1
Vaso-Occlusive Crises
1
Sarcoma
1
Prostatic Neoplasms
1
Pain
1
Neurotoxicity Syndromes
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia
1
Kidney Neoplasms
1
Esophagitis
1
Dendritic Cell Sarcoma, Interdigitating
1
Burkitt Lymphoma
1
Anemia, Sickle Cell
1
Interventions
Oxaliplatin
53
Cisplatin
52
Fluorouracil
50
Capecitabine
48
pembrolizumab
39
Leucovorin
31
Docetaxel
26
Trastuzumab
23
Paclitaxel
20
Irinotecan
20
Ramucirumab
13
Bevacizumab
12
Cetuximab
9
Radiotherapy
8
Surgical Procedures, Operative
7
S 1 (combination)
7
Nivolumab
7
Epirubicin
7
Carboplatin
6
olaparib
5
Platinum
5
Everolimus
5
Sunitinib
4
Mitomycin
4
trastuzumab deruxtecan
3
lenvatinib
3
epacadostat
3
bemarituzumab
3
apatinib
3
Saline Solution
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Stomach Neoplasms
×
Glutamine
×
Clear all
No trials found.